Literature DB >> 2482147

Murine leukaemia virus gene product as an acute phase protein: complete suppression of serum gp70 synthesis in hepatocytes of B10.S mice.

K Shigemoto1, N Maruyama, Y Itoh, S Kubo, T Koike.   

Abstract

The Sgp-1c trait is associated with H-2s and relates to the small content of serum gp70 as well as the lack of serum gp70 responsiveness to lipopolysaccharide (LPS). Northern hybridization of RNA from B10.S liver and its hybrid with NZB showed that the suppression of gp70 in Sgp-1c carrying mice can be regulated at the transcriptional level. However, the inheritance of this trait shows the complicated manner of segregation in certain crosses. All (B10.S x NZB) F1 hybrid mice and F1 x B10.S back-cross mice had low amounts of serum gp70 and did not respond to LPS with increased levels of serum gp70. In contrast, F1 x NZB back-cross progeny varied widely in serum gp70 levels. The serum gp70 levels of most F1 x NZB back-cross mice was increased by LPS, although the range of increases was broad. These results indicate that the Sgp-1c alone is not sufficient to lower serum gp70 levels, unless B10 background is present. The expression of Sgp-1 system, which is linked with the H-2 region, requires non-H-2-linked genes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2482147      PMCID: PMC1534823     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  XenCSA: cell surface antigens related to the major glycoproteins (gp70) of xenotropic murine leukemia viruses.

Authors:  H C Morse; T M Chused; M Boehm-Truitt; B J Mathieson; S O Sharrow; J W Hartley
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

2.  A genetic locus regulates the expression of tissue-specific mRNAs from multiple transcription units.

Authors:  D E Levy; R A Lerner; M C Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

3.  Serum gp70 production regulated by a gene on murine chromosome 7.

Authors:  N Maruyama; C O Lindstrom; H Sato; F J Dixon
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

4.  H-2-linked regulation of serum gp70 production in mice.

Authors:  N Maruyama; C O Lindstrom
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

5.  H-2-linked regulation of xenotropic murine leukemia virus expression.

Authors:  R A Yetter; J W Hartley; H C Morse
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

6.  Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease.

Authors:  N Maruyama; F Furukawa; Y Nakai; Y Sasaki; K Ohta; S Ozaki; S Hirose; T Shirai
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

7.  Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus.

Authors:  S Izui; P J McConahey; A N Theofilopoulos; F J Dixon
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

8.  Genetic studies of autoimmunity and retrovirus expression in crosses of New Zealand black mice. II. The viral envelope glycoprotein gp70.

Authors:  S K Datta; P J McConahey; N Manny; A N Theofilopoulos; F J Dixon; R S Schwartz
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

9.  Murine serum glycoprotein gp70 behaves as an acute phase reactant.

Authors:  I Hara; S Izui; F J Dixon
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

10.  The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice.

Authors:  T Yoshiki; R C Mellors; M Strand; J T August
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  1 in total

1.  Induction of endogenous retroviral gene product (SU) as an acute-phase protein by IL-6 in murine hepatocytes.

Authors:  Y Itoh; N Maruyama; M Kitamura; T Shirasawa; K Shigemoto; T Koike
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.